Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized trial to compare twice-daily vs once-daily tacrolimus in lung transplant patients
2009-011324-60Phase 3Terminated
- Sponsor
- Hannover Medical School
- Start
- Mar 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tacrolimus in heart-lung transplant recipient status (2 arms), sponsored by Hannover Medical School. Started Mar 2009; status: terminated.
02
Drugs
tacrolimus
03
Conditions
heart-lung transplant recipient status
Beyond the preview
Go deeper on 2009-011324-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011324-60.